Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of ENG-E2 vaginal ring for primary dysmenorrhea
2015-004325-14Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in primary dysmenorrhea (PD) comparing MK-8342B (ENG-E2 vaginal ring) with Placebo vaginal ring (2 arms). Primary endpoint: Composite responder endpoint at treatment cycle 2. Started Dec 2015; status: completed.
02
Drugs
etonogestrel + ethinyl estradiol
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on 2015-004325-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004325-14.